Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 25, 2026, 8:36 am
Author: Getaka|Social: XLinkedIn

Meghmani Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 25, 2026, 8:36 am

Market Cap 1,299 Cr.
Current Price 51.1
Intrinsic Value₹8.51
High / Low 106/50.5
Stock P/E32.1
Book Value 60.6
Dividend Yield0.00 %
ROCE3.39 %
ROE0.80 %
Face Value 1.00
PEG Ratio-0.97

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Meghmani Organics Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Epigral Ltd 4,026 Cr. 933 2,114/90311.9 4870.65 %24.9 %22.3 % 10.0
Dharmaj Crop Guard Ltd 794 Cr. 235 391/16816.4 1310.00 %12.0 %9.28 % 10.0
Bhaskar Agrochemicals Ltd 63.5 Cr. 122 149/56.69.83 40.00.82 %21.3 %24.7 % 10.0
Bhagiradha Chemicals & Industries Ltd 2,632 Cr. 203 331/198109 54.90.07 %7.44 %4.91 % 1.00
Best Agrolife Ltd 626 Cr. 17.6 35.8/16.325.8 22.81.13 %12.9 %9.95 % 1.00
Industry Average10,182.10 Cr1,082.3627.51369.000.49%15.21%19.87%6.67

All Competitor Stocks of Meghmani Organics Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 549.43574.08425.78378.72351.75410.03413.88543.89568.51553.46613.62577.26508.74
Expenses 496.54496.18447.87371.13359.55408.01408.01513.32527.69487.98546.73525.17471.01
Operating Profit 52.8977.90-22.097.59-7.802.025.8730.5740.8265.4866.8952.0937.73
OPM % 9.63%13.57%-5.19%2.00%-2.22%0.49%1.42%5.62%7.18%11.83%10.90%9.02%7.42%
Other Income 23.9827.417.0112.109.638.958.8811.979.1413.8816.5827.7614.84
Interest 43.3415.754.4712.7726.632.4910.5826.2212.8819.3229.4723.7818.13
Depreciation 18.0922.5823.5922.7123.1322.8023.4825.4929.6729.4929.7029.9829.94
Profit before tax 15.4466.98-43.14-15.79-47.93-14.32-19.31-9.177.4130.5524.3026.094.50
Tax % 45.92%19.15%-20.03%-2.85%-20.26%25.42%-13.26%1.09%159.24%35.12%47.78%55.73%178.67%
Net Profit 8.3554.15-34.50-15.34-38.23-17.96-16.76-9.27-4.3919.8212.6811.55-3.53
EPS in Rs 0.332.13-1.36-0.60-1.50-0.71-0.66-0.36-0.170.780.500.45-0.14

Last Updated: February 5, 2026, 12:41 am

Below is a detailed analysis of the quarterly data for Meghmani Organics Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 508.74 Cr.. The value appears to be declining and may need further review. It has decreased from 577.26 Cr. (Sep 2025) to 508.74 Cr., marking a decrease of 68.52 Cr..
  • For Expenses, as of Dec 2025, the value is 471.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 525.17 Cr. (Sep 2025) to 471.01 Cr., marking a decrease of 54.16 Cr..
  • For Operating Profit, as of Dec 2025, the value is 37.73 Cr.. The value appears to be declining and may need further review. It has decreased from 52.09 Cr. (Sep 2025) to 37.73 Cr., marking a decrease of 14.36 Cr..
  • For OPM %, as of Dec 2025, the value is 7.42%. The value appears to be declining and may need further review. It has decreased from 9.02% (Sep 2025) to 7.42%, marking a decrease of 1.60%.
  • For Other Income, as of Dec 2025, the value is 14.84 Cr.. The value appears to be declining and may need further review. It has decreased from 27.76 Cr. (Sep 2025) to 14.84 Cr., marking a decrease of 12.92 Cr..
  • For Interest, as of Dec 2025, the value is 18.13 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 23.78 Cr. (Sep 2025) to 18.13 Cr., marking a decrease of 5.65 Cr..
  • For Depreciation, as of Dec 2025, the value is 29.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 29.98 Cr. (Sep 2025) to 29.94 Cr., marking a decrease of 0.04 Cr..
  • For Profit before tax, as of Dec 2025, the value is 4.50 Cr.. The value appears to be declining and may need further review. It has decreased from 26.09 Cr. (Sep 2025) to 4.50 Cr., marking a decrease of 21.59 Cr..
  • For Tax %, as of Dec 2025, the value is 178.67%. The value appears to be increasing, which may not be favorable. It has increased from 55.73% (Sep 2025) to 178.67%, marking an increase of 122.94%.
  • For Net Profit, as of Dec 2025, the value is -3.53 Cr.. The value appears to be declining and may need further review. It has decreased from 11.55 Cr. (Sep 2025) to -3.53 Cr., marking a decrease of 15.08 Cr..
  • For EPS in Rs, as of Dec 2025, the value is -0.14. The value appears to be declining and may need further review. It has decreased from 0.45 (Sep 2025) to -0.14, marking a decrease of 0.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 1:16 am

MetricMar 2020n n 6mMar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 7001,6372,4982,5531,5662,0802,253
Expenses 5951,3532,1192,2111,5861,9362,031
Operating Profit 105283379342-19144222
OPM % 15%17%15%13%-1%7%10%
Other Income 13030102114374273
Interest 1811966466991
Depreciation 2251637792108119
Profit before tax 194252409313-121985
Tax % 23%26%26%24%-12%212%
Net Profit 150186304238-106-1141
EPS in Rs 29,914.0037,296.0011.979.35-4.17-0.421.59
Dividend Payout % 17%19%12%15%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)63.44%-21.71%-144.54%89.62%
Change in YoY Net Profit Growth (%)0.00%-85.15%-122.83%234.16%

Meghmani Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:24%
3 Years:-6%
TTM:47%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:121%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-13%
1 Year:-25%
Return on Equity
10 Years:%
5 Years:8%
3 Years:2%
Last Year:-1%

Last Updated: Unknown

Balance Sheet

Last Updated: December 4, 2025, 1:38 am

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 25252525252525
Reserves 9611,1481,4411,6441,5021,4901,514
Borrowings 264268499824837829841
Other Liabilities 407533832705674741905
Total Liabilities 1,6571,9742,7983,1983,0393,0853,285
Fixed Assets 4816349111,1661,1521,5751,540
CWIP 1011121883565218380
Investments 19130421118311433
Other Assets 8859241,4871,4941,2511,4251,662
Total Assets 1,6571,9742,7983,1983,0393,0853,285

Below is a detailed analysis of the balance sheet data for Meghmani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
  • For Reserves, as of Sep 2025, the value is 1,514.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,490.00 Cr. (Mar 2025) to 1,514.00 Cr., marking an increase of 24.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 841.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 829.00 Cr. (Mar 2025) to 841.00 Cr., marking an increase of 12.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 905.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 741.00 Cr. (Mar 2025) to 905.00 Cr., marking an increase of 164.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 3,285.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 1,540.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,575.00 Cr. (Mar 2025) to 1,540.00 Cr., marking a decrease of 35.00 Cr..
  • For CWIP, as of Sep 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 3.00 Cr..
  • For Investments, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 1,662.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,425.00 Cr. (Mar 2025) to 1,662.00 Cr., marking an increase of 237.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 3,285.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..

Notably, the Reserves (1,514.00 Cr.) exceed the Borrowings (841.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 223336520425066
Cash from Investing Activity + 13-307-133-418-17831
Cash from Financing Activity + -26-1458234-85-91
Net Cash Flow 812-1021-146

Free Cash Flow

MonthMar 2020n n 6mMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow105.0015.00-120.00-482.00-856.00-685.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 24192797510199
Inventory Days 271152161158185173
Days Payable 209137144108176159
Cash Conversion Cycle 30210696124110113
Working Capital Days 1528957532620
ROCE %19%24%16%-3%3%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 49.48%49.50%49.32%49.32%49.32%49.32%49.33%49.33%49.41%48.98%48.98%48.98%
FIIs 1.53%1.50%1.34%1.30%1.52%1.39%2.22%1.90%1.81%1.94%1.48%1.33%
DIIs 0.45%0.45%0.61%0.26%0.20%0.20%0.42%0.27%0.48%0.37%0.00%0.00%
Government 0.05%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%
Public 48.50%48.51%48.69%49.09%48.93%49.05%47.98%48.46%48.24%48.68%49.50%49.65%
No. of Shareholders 1,27,1981,31,3361,40,6721,40,8291,52,7031,46,0101,28,8751,27,3921,26,6171,28,0821,31,8531,35,031

Shareholding Pattern Chart

No. of Shareholders

Meghmani Organics Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal Nifty Microcap 250 Index Fund 140,745 0.19 1.06140,7452025-04-22 05:19:080%
Groww Nifty Total Market Index Fund 369 0.01 03692025-04-22 17:25:260%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) -0.42-4.179.3511.977.33
Diluted EPS (Rs.) -0.42-4.179.3511.977.33
Cash EPS (Rs.) 3.83-0.5412.3814.439.33
Book Value[Excl.RevalReserv]/Share (Rs.) 59.5860.0765.6457.6546.13
Book Value[Incl.RevalReserv]/Share (Rs.) 59.5860.0765.6457.6546.13
Revenue From Operations / Share (Rs.) 81.7861.59100.3798.2464.36
PBDIT / Share (Rs.) 7.340.6817.1918.6712.08
PBIT / Share (Rs.) 3.09-2.9414.1616.2010.09
PBT / Share (Rs.) 0.37-4.7612.3116.079.90
Net Profit / Share (Rs.) -0.41-4.179.3511.977.33
NP After MI And SOA / Share (Rs.) -0.41-4.179.3511.977.33
PBDIT Margin (%) 8.971.1117.1219.0018.76
PBIT Margin (%) 3.77-4.7714.1016.4915.67
PBT Margin (%) 0.45-7.7312.2616.3615.38
Net Profit Margin (%) -0.50-6.769.3112.1811.39
NP After MI And SOA Margin (%) -0.50-6.769.3112.1811.39
Return on Networth / Equity (%) -0.69-6.9414.2420.7615.89
Return on Capital Employeed (%) 4.17-3.7716.6023.3718.85
Return On Assets (%) -0.34-3.487.4310.889.44
Long Term Debt / Equity (X) 0.180.250.240.140.10
Total Debt / Equity (X) 0.540.540.490.330.18
Asset Turnover Ratio (%) 0.670.500.851.060.89
Current Ratio (X) 1.121.151.421.391.62
Quick Ratio (X) 0.620.650.790.771.01
Inventory Turnover Ratio (X) 3.731.552.353.182.81
Dividend Payout Ratio (NP) (%) 0.00-33.5814.9711.690.00
Dividend Payout Ratio (CP) (%) 0.00-257.9611.319.690.00
Earning Retention Ratio (%) 0.00133.5885.0388.310.00
Cash Earning Retention Ratio (%) 0.00357.9688.6990.310.00
Interest Coverage Ratio (X) 2.700.376.6550.4527.44
Interest Coverage Ratio (Post Tax) (X) 0.84-1.294.3332.7017.08
Enterprise Value (Cr.) 2357.582831.392761.813135.900.00
EV / Net Operating Revenue (X) 1.131.811.081.260.00
EV / EBITDA (X) 12.63162.666.326.610.00
MarketCap / Net Operating Revenue (X) 0.741.290.771.060.00
Retention Ratios (%) 0.00133.5885.0288.300.00
Price / BV (X) 1.031.321.181.810.00
Price / Net Operating Revenue (X) 0.741.290.771.060.00
EarningsYield -0.01-0.050.120.110.00

After reviewing the key financial ratios for Meghmani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
  • For Diluted EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
  • For Cash EPS (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has increased from -0.54 (Mar 24) to 3.83, marking an increase of 4.37.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 81.78. It has increased from 61.59 (Mar 24) to 81.78, marking an increase of 20.19.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 7.34. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 7.34, marking an increase of 6.66.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 3.09. This value is within the healthy range. It has increased from -2.94 (Mar 24) to 3.09, marking an increase of 6.03.
  • For PBT / Share (Rs.), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from -4.76 (Mar 24) to 0.37, marking an increase of 5.13.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
  • For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 1.11 (Mar 24) to 8.97, marking an increase of 7.86.
  • For PBIT Margin (%), as of Mar 25, the value is 3.77. This value is below the healthy minimum of 10. It has increased from -4.77 (Mar 24) to 3.77, marking an increase of 8.54.
  • For PBT Margin (%), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 10. It has increased from -7.73 (Mar 24) to 0.45, marking an increase of 8.18.
  • For Net Profit Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 5. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 8. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
  • For Return on Networth / Equity (%), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 15. It has increased from -6.94 (Mar 24) to -0.69, marking an increase of 6.25.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 4.17. This value is below the healthy minimum of 10. It has increased from -3.77 (Mar 24) to 4.17, marking an increase of 7.94.
  • For Return On Assets (%), as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has increased from -3.48 (Mar 24) to -0.34, marking an increase of 3.14.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.18, marking a decrease of 0.07.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.54.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.67. It has increased from 0.50 (Mar 24) to 0.67, marking an increase of 0.17.
  • For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has decreased from 1.15 (Mar 24) to 1.12, marking a decrease of 0.03.
  • For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.62, marking a decrease of 0.03.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.73. This value is below the healthy minimum of 4. It has increased from 1.55 (Mar 24) to 3.73, marking an increase of 2.18.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -33.58 (Mar 24) to 0.00, marking an increase of 33.58.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -257.96 (Mar 24) to 0.00, marking an increase of 257.96.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 357.96 (Mar 24) to 0.00, marking a decrease of 357.96.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 2.70. This value is below the healthy minimum of 3. It has increased from 0.37 (Mar 24) to 2.70, marking an increase of 2.33.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 3. It has increased from -1.29 (Mar 24) to 0.84, marking an increase of 2.13.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 2,357.58. It has decreased from 2,831.39 (Mar 24) to 2,357.58, marking a decrease of 473.81.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.13. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.13, marking a decrease of 0.68.
  • For EV / EBITDA (X), as of Mar 25, the value is 12.63. This value is within the healthy range. It has decreased from 162.66 (Mar 24) to 12.63, marking a decrease of 150.03.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
  • For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
  • For Price / BV (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 1.32 (Mar 24) to 1.03, marking a decrease of 0.29.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
  • For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to -0.01, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Meghmani Organics Ltd as of February 25, 2026 is: ₹12.70

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 25, 2026, Meghmani Organics Ltd is Overvalued by 75.15% compared to the current share price ₹51.10

Intrinsic Value of Meghmani Organics Ltd as of February 25, 2026 is: ₹8.48

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 25, 2026, Meghmani Organics Ltd is Overvalued by 83.41% compared to the current share price ₹51.10

Last 5 Year EPS CAGR: -33.22%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (1,385.71 cr) compared to borrowings (623.14 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (101.43 cr) and profit (163.00 cr) over the years.
  1. The stock has a low average ROCE of 9.83%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 66.17, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 141.83, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Meghmani Organics Ltd:
    1. Net Profit Margin: -0.5%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 4.17% (Industry Average ROCE: 15.21%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: -0.69% (Industry Average ROE: 19.87%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 0.84
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.62
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 32.1 (Industry average Stock P/E: 27.51)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.54
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Meghmani Organics Ltd. is a Public Limited Listed company incorporated on 15/10/2019 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24299GJ2019PLC110321 and registration number is 110321. Currently Company is involved in the business activities of Manufacture of dyes and pigments from any source in basic form or as concentrate. Company's Total Operating Revenue is Rs. 2003.87 Cr. and Equity Capital is Rs. 25.43 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Agro Chemicals/Pesticides1st to 3rd Floor, Near Raj Bunglow, Ahmedabad Gujarat 380015Contact not found
Management
NamePosition Held
Mr. Ankit PatelChairman & Managing Director
Mr. Karana PatelExecutive Director
Mr. Darshan PatelExecutive Director
Mr. Maulik PatelNon Executive Director
Mr. Kaushal SoparkarNon Executive Director
Ms. Urvashi D ShahIndependent Director
Mr. Manubhai K PatelIndependent Director
Prof. (Dr) Ganapati YadavIndependent Director
Dr. Varesh Govindprasad SinhaIndependent Director
Mr. Nikunt RavalIndependent Director

FAQ

What is the intrinsic value of Meghmani Organics Ltd?

Meghmani Organics Ltd's intrinsic value (as of 25 February 2026) is ₹8.48 which is 83.41% lower the current market price of ₹51.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,299 Cr. market cap, FY2025-2026 high/low of ₹106/50.5, reserves of ₹1,514 Cr, and liabilities of ₹3,285 Cr.

What is the Market Cap of Meghmani Organics Ltd?

The Market Cap of Meghmani Organics Ltd is 1,299 Cr..

What is the current Stock Price of Meghmani Organics Ltd as on 25 February 2026?

The current stock price of Meghmani Organics Ltd as on 25 February 2026 is ₹51.1.

What is the High / Low of Meghmani Organics Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Meghmani Organics Ltd stocks is ₹106/50.5.

What is the Stock P/E of Meghmani Organics Ltd?

The Stock P/E of Meghmani Organics Ltd is 32.1.

What is the Book Value of Meghmani Organics Ltd?

The Book Value of Meghmani Organics Ltd is 60.6.

What is the Dividend Yield of Meghmani Organics Ltd?

The Dividend Yield of Meghmani Organics Ltd is 0.00 %.

What is the ROCE of Meghmani Organics Ltd?

The ROCE of Meghmani Organics Ltd is 3.39 %.

What is the ROE of Meghmani Organics Ltd?

The ROE of Meghmani Organics Ltd is 0.80 %.

What is the Face Value of Meghmani Organics Ltd?

The Face Value of Meghmani Organics Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Meghmani Organics Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports